Insiders · Profile

BOHLIN GAREN G

Director at COLLEGIUM PHARMACEUTICAL · Director at Karyopharm Therapeutics. Filing since 6 May 2021. CIK 0001254705

Company

Date

Role

Action

Amount

Of holding

11 May 2026

Director

Sold at will

8,700

$323.49K

12.3%

14 May 2024

Director

Sold at will

28,985

$936.31K

39.3%

12 Sep 2023

Director

Bought

41,140

$49.99K

×10

6 May 2021

Director

Bought

4,000

$31.28K

opened

4 decisions on file.